相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Pathological tau and reactive astrogliosis are associated with distinct functional deficits in a mouse model of tauopathy
Henika Patel et al.
NEUROBIOLOGY OF AGING (2022)
Medha Plus-A novel polyherbal formulation ameliorates cognitive behaviors and disease pathology in models of Alzheimer?s disease
Ramesh Kumar Paidi et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Efficacy and Safety of a Brain-Penetrant Biologic TNF-α Inhibitor in Aged APP/PS1 Mice
Weijun Ou et al.
PHARMACEUTICS (2022)
2022 Alzheimer's disease facts and figures
Joseph Gaugler et al.
ALZHEIMERS & DEMENTIA (2022)
A Phase 2/3 Trial of Pabinafusp Alfa, IDS Fused with Anti-Human Transferrin Receptor Antibody, Targeting Neurodegeneration in MPS-II
Torayuki Okuyama et al.
MOLECULAR THERAPY (2021)
Erythropoietin-derived peptide treatment reduced neurological deficit and neuropathological changes in a mouse model of tauopathy
Yun-Beom Choi et al.
ALZHEIMERS RESEARCH & THERAPY (2021)
Biologic TNF-α inhibitors reduce microgliosis, neuronal loss, and tau phosphorylation in a transgenic mouse model of tauopathy
Weijun Ou et al.
JOURNAL OF NEUROINFLAMMATION (2021)
Behavioural Functions and Cerebral Blood Flow in a P301S Tauopathy Mouse Model: A Time-Course Study
Faraz Ahmad et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Nonclinical safety evaluation of pabinafusp alfa, an anti-human transferrin receptor antibody and iduronate-2-sulfatase fusion protein, for the treatment of neuronopathic mucopolysaccharidosis type II
Ryuji Yamamoto et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2021)
The behavioural and neuropathologic sexual dimorphism and absence of MIP-3α in tau P301S mouse model of Alzheimer's disease
Yao Sun et al.
JOURNAL OF NEUROINFLAMMATION (2020)
Microglial activation arises after aggregation of phosphorylated-tau in a neuron-specific P301S tauopathy mouse model
Lynn van Olst et al.
NEUROBIOLOGY OF AGING (2020)
Microglial activation and tau burden predict cognitive decline in Alzheimer's disease
Maura Malpetti et al.
BRAIN (2020)
Eliminating Fc N-Linked Glycosylation and Its Impact on Dosing Consideration for a Transferrin Receptor Antibody-Erythropoietin Fusion Protein in Mice
Joshua Yang et al.
MOLECULAR PHARMACEUTICS (2020)
Microglia Implicated in Tauopathy in the Striatum of Neurodegenerative Disease Patients from Genotype to Phenotype
Huifangjie Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Acute and Chronic Dosing of a High-Affinity Rat/Mouse Chimeric Transferrin Receptor Antibody in Mice
Demi M. Castellanos et al.
PHARMACEUTICS (2020)
Plasma Pharmacokinetics of High-Affinity Transferrin Receptor Antibody-Erythropoietin Fusion Protein is a Function of Effector Attenuation in Mice
Jiahong Sun et al.
MOLECULAR PHARMACEUTICS (2019)
Intersection of pathological tau and microglia at the synapse
Thomas Vogels et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
The Promises and Challenges of Erythropoietin for Treatment of Alzheimer's Disease
Jiahong Sun et al.
NEUROMOLECULAR MEDICINE (2019)
Hematologic safety of chronic brain-penetrating erythropoietin dosing in APP/PS1 mice
Jiahong Sun et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2019)
Reducing the RNA binding protein TIA1 protects against tau-mediated neurodegeneration in vivo
Daniel J. Apicco et al.
NATURE NEUROSCIENCE (2018)
The Role of Microglia in the Spread of Tau: Relevance for Tauopathies
Juan R. Perea et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
Brain Penetrating Bifunctional Erythropoietin-Transferrin Receptor Antibody Fusion Protein for Alzheimer's Disease
Rudy Chang et al.
MOLECULAR PHARMACEUTICS (2018)
Soluble Tau has devastating effects on the structural plasticity of hippocampal granule neurons
M. Bolos et al.
TRANSLATIONAL PSYCHIATRY (2017)
From Erythroblasts to Mature Red Blood Cells: Organelle Clearance in Mammals
Martina Moras et al.
FRONTIERS IN PHYSIOLOGY (2017)
Neuronal Cell Death and Degeneration through Increased Nitroxidative Stress and Tau Phosphorylation in HIV-1 Transgenic Rats
Young-Eun Cho et al.
PLOS ONE (2017)
Delivery of Biologics Across the Blood-Brain Barrier with Molecular Trojan Horse Technology
William M. Pardridge
BIODRUGS (2017)
Downstream modulation of extrinsic apoptotic pathway in streptozotocin-induced Alzheimer's dementia in rats: Erythropoietin versus curcumin
Doaa M. Samy et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Neuroinflammation in Alzheimer's disease
Michael T. Heneka et al.
LANCET NEUROLOGY (2015)
Widespread Expression of Erythropoietin Receptor in Brain and Its Induction by Injury
Christoph Ott et al.
MOLECULAR MEDICINE (2015)
Memory Improvement in the A beta PP/PS1 Mouse Model of Familial Alzheimer's Disease Induced by Carbamylated-Erythropoietin is Accompanied by Modulation of Synaptic Genes
Mercedes Armand-Ugon et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Evidence that erythropoietin modulates neuroinflammation through differential action on neurons, astrocytes, and microglia
Wesley S. Bond et al.
FRONTIERS IN IMMUNOLOGY (2014)
Synthetic Tau Fibrils Mediate Transmission of Neurofibrillary Tangles in a Transgenic Mouse Model of Alzheimer's-Like Tauopathy
Michiyo Iba et al.
JOURNAL OF NEUROSCIENCE (2013)
Pharmacokinetics and Brain Uptake of an IgG-TNF Decoy Receptor Fusion Protein Following Intravenous, Intraperitoneal, and Subcutaneous Administration in Mice
Rachita K. Sumbria et al.
MOLECULAR PHARMACEUTICS (2013)
Physiology and Pharmacology of Erythropoietin
Wolfgang Jelkmann
TRANSFUSION MEDICINE AND HEMOTHERAPY (2013)
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
Peter T. Nelson et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
Erythropoietin: still on the neuroprotection road
Nelvys Subiros et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2012)
Behavioral deficit, oxidative stress, and mitochondrial dysfunction precede tau pathology in P301S transgenic mice
Magali Dumont et al.
FASEB JOURNAL (2011)
P301S Mutant Human Tau Transgenic Mice Manifest Early Symptoms of Human Tauopathies with Dementia and Altered Sensorimotor Gating
Hiroki Takeuchi et al.
PLOS ONE (2011)
Early behavioural markers of disease in P301S tau transgenic mice
Maria Luisa Scattoni et al.
BEHAVIOURAL BRAIN RESEARCH (2010)
Tau in Alzheimer Disease and Related Tauopathies
K. Iqbal et al.
CURRENT ALZHEIMER RESEARCH (2010)
Erythropoietin molecules to treat acute ischemic stroke: a translational dilemma!
Paul A. Lapchak
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Drug Targeting of Erythropoietin Across the Primate Blood-Brain Barrier with an IgG Molecular Trojan Horse
Ruben J. Boado et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Re-Engineering Erythropoietin as an IgG Fusion Protein That Penetrates the Blood-Brain Barrier in the Mouse
Qing-Hui Zhou et al.
MOLECULAR PHARMACEUTICS (2010)
Enhanced Delivery of Erythropoietin Across the Blood-Brain Barrier for Neuroprotection Against Ischemic Neuronal Injury
Feng Zhang et al.
TRANSLATIONAL STROKE RESEARCH (2010)
Erythropoietin as neuroprotective and neuroregenerative treatment strategy: Comprehensive overview of 12 years of preclinical and clinical research
Derya Sargin et al.
BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY (2010)
Microglial activation in brain lesions with tau deposits:: Comparison of human tauopathies and tau transgenic mice TgTauP301L
Atsushi Sasaki et al.
BRAIN RESEARCH (2008)
Protective effect of erythropoietin on β-amyloid-induced PC12 cell death through antioxidant mechanisms
Gang Li et al.
NEUROSCIENCE LETTERS (2008)
Iron trafficking inside the brain
Torben Moos et al.
JOURNAL OF NEUROCHEMISTRY (2007)
A classical homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells
Moonkyoung Um et al.
CELLULAR SIGNALLING (2007)
Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model
Yasumasa Yoshiyama et al.
NEURON (2007)
Passage of erythropoietic agents across the blood-brain barrier: a comparison of human and murine erythropoietin and the analog darbepoetin alfa
WA Banks et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Blood-brain barrier genomics
JY Li et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2001)